Live Breaking News & Updates on Clinical Updates|Page 5
Stay updated with breaking news from Clinical updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Special AAFP Session Offers Updates on COVID-19 Vaccines CME Credit Available for Participants January 19, 2021, 12:37 pm News Staff With new information about vaccines for COVID-19 coming on a daily basis, it’s understandable that family physicians have questions about the vaccines, not just for patients, but for themselves as well and the AAFP is here to provide answers. On Jan. 26, the Academy will host a special panel session, Three panelists will discuss the science behind the new vaccines, as well as what the vaccines mean to FPs and their patients. Topics scheduled to be covered include clinical and practical considerations for the two currently available COVID-19 vaccines; ....
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates Anavex Life Sciences Corp.December 28, 2020 GMT NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal year ended September 30, 2020. Christopher U Missling, PhD, President and Chief Executive Officer of Anavex said: “Despite all of the new challenges, 2020 was an extraordinary year for Anavex, with significant progress across our portfolio, including our first positive, placebo-controlled, U ....